$1.60
-0.05-3.03%
最終更新: Oct 16, 11:37 AM
Benzinga
Benzinga
Benzinga
金曜日, 10 16
Benzinga
© 2026 Benzinga | All Rights Reserved
INmune Bio (INMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.21 | $-0.27 | $-0.32 |
| Actual | $-0.05 | $-0.20 | $-0.18 | $-0.24 |
| Surprise | +75.0% | +4.76% | +33.3% | +25.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.18 | $-0.17 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.05 | $-0.20 | 75.0 % |
| Q1 | May 7, 2026 | $-0.20 | $-0.21 | 4.76 % |
| Q4 | Mar 30, 2026 | $-0.18 | $-0.27 | 33.3 % |
| Q3 | Oct 30, 2025 | $-0.24 | $-0.32 | 25.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q1 | May 9, 2024 | $14.00K | $30.00K | -53.3 % |
| Q4 | Mar 28, 2024 | $28.00K | $40.00K | -30.0 % |
| Q3 | Nov 3, 2021 | $14.00K | $970.00K | -98.6 % |